Novartis AG
NVSEF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $12 | $9 | $7 | $24 |
| Dep. & Amort. | $6 | $8 | $7 | $6 |
| Deferred Tax | $2 | $1 | $1 | $2 |
| Stock-Based Comp. | $1 | $1 | $1 | $1 |
| Change in WC | -$1 | -$0 | -$1 | $0 |
| Other Non-Cash | -$2 | -$4 | -$1 | -$18 |
| Operating Cash Flow | $18 | $14 | $14 | $15 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$3 | -$3 | -$3 |
| Net Acquisitions | -$4 | -$4 | -$1 | $20 |
| Inv. Purchases | -$4 | -$1 | -$35 | -$17 |
| Inv. Sales/Matur. | $4 | $12 | $39 | $3 |
| Other Inv. Act. | -$2 | $1 | $0 | $1 |
| Investing Cash Flow | -$8 | $6 | $1 | $4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $4 | -$2 | -$2 | -$2 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$8 | -$9 | -$11 | -$3 |
| Dividends Paid | -$8 | -$7 | -$8 | -$7 |
| Other Fin. Act. | -$0 | $3 | -$0 | -$3 |
| Financing Cash Flow | -$12 | -$14 | -$21 | -$16 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | -$2 | $6 | -$5 | $3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13 | $8 | $12 | $10 |
| End Cash | $11 | $13 | $8 | $12 |
| Free Cash Flow | $14 | $12 | $12 | $12 |